Apogee Therapeutics, Inc. (APGE)
134.79
+0.04
(+0.03%)
USD |
NASDAQ |
Aug 24, 16:00
134.87
+0.08
(+0.06%)
After-Hours: 05:50
Apogee Therapeutics Total Return Level : 134.79 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 134.79 |
| August 21, 2026 | 134.75 |
| August 20, 2026 | 134.75 |
| August 19, 2026 | 134.71 |
| August 18, 2026 | 134.57 |
| August 17, 2026 | 134.59 |
| August 14, 2026 | 134.55 |
| August 13, 2026 | 134.45 |
| August 12, 2026 | 134.55 |
| August 11, 2026 | 134.69 |
| August 10, 2026 | 134.65 |
| August 07, 2026 | 134.84 |
| August 06, 2026 | 134.49 |
| August 05, 2026 | 134.23 |
| August 04, 2026 | 134.19 |
| August 03, 2026 | 134.11 |
| July 31, 2026 | 134.09 |
| July 30, 2026 | 134.30 |
| July 29, 2026 | 134.20 |
| July 28, 2026 | 134.17 |
| July 27, 2026 | 134.28 |
| July 24, 2026 | 134.28 |
| July 23, 2026 | 134.26 |
| July 22, 2026 | 134.08 |
| July 21, 2026 | 134.20 |
| Date | Value |
|---|---|
| July 20, 2026 | 134.15 |
| July 17, 2026 | 134.00 |
| July 16, 2026 | 134.08 |
| July 15, 2026 | 134.29 |
| July 14, 2026 | 133.96 |
| July 13, 2026 | 133.82 |
| July 10, 2026 | 133.65 |
| July 09, 2026 | 133.57 |
| July 08, 2026 | 133.25 |
| July 07, 2026 | 133.54 |
| July 06, 2026 | 133.50 |
| July 02, 2026 | 132.91 |
| July 01, 2026 | 132.77 |
| June 30, 2026 | 132.73 |
| June 29, 2026 | 132.61 |
| June 26, 2026 | 132.55 |
| June 25, 2026 | 132.68 |
| June 24, 2026 | 132.69 |
| June 23, 2026 | 132.88 |
| June 22, 2026 | 132.55 |
| June 18, 2026 | 90.38 |
| June 17, 2026 | 88.43 |
| June 16, 2026 | 85.24 |
| June 15, 2026 | 86.19 |
| June 12, 2026 | 88.33 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Cogent Biosciences, Inc. | 36.23 |
| Arrowhead Pharmaceuticals, Inc. | 86.73 |
| Intellia Therapeutics, Inc. | 12.56 |
| Revolution Medicines, Inc. | 211.58 |
| Erasca, Inc. | 17.60 |